UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 6.609

Sortiert nach

Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries

Australian & New Zealand Journal of Psychiatry, 2014-06, Vol.48 (6), p.512-529

2014

Link zum Volltext

Verfügbarkeit prüfen

Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth

Canadian journal of psychiatry, 2017-09, Vol.62 (9), p.635-647

2017

Link zum Volltext

Verfügbarkeit prüfen

Neurocognition: Clinical and Functional Outcomes in Schizophrenia

Canadian journal of psychiatry, 2014-01, Vol.59 (1), p.5-12

2014

Link zum Volltext

Verfügbarkeit prüfen

Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis

Australian & New Zealand Journal of Psychiatry, 2018-08, Vol.52 (8), p.751-767

2018

Link zum Volltext

Verfügbarkeit prüfen

The Core of Classical Schizophrenia

Canadian journal of psychiatry, 2020-04, Vol.65 (4), p.235-236

Liddle, Peter F.

2020

Link zum Volltext

Verfügbarkeit prüfen

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Australian and New Zealand journal of psychiatry, 2016-05, Vol.50 (5), p.410-472

2016

Link zum Volltext

Verfügbarkeit prüfen

Glutamate and dopamine in schizophrenia: An update for the 21st century

Journal of Psychopharmacology, 2015-02, Vol.29 (2), p.97-115

2015

Link zum Volltext

Verfügbarkeit prüfen

Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults

Canadian journal of psychiatry, 2017-09, Vol.62 (9), p.617-623

2017

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for the Pharmacotherapy of Schizophrenia in Adults

Canadian journal of psychiatry, 2017-09, Vol.62 (9), p.604-616

2017

Link zum Volltext

Verfügbarkeit prüfen

A Psychopathological Comparison between Delusional Disorder and Schizophrenia

Canadian journal of psychiatry, 2018-01, Vol.63 (1), p.12-19

2018

Link zum Volltext

Verfügbarkeit prüfen

Australian Schizophrenia Research Bank: A Database of Comprehensive Clinical, Endophenotypic and Genetic Data for Aetiological Studies of Schizophrenia

Australian and New Zealand journal of psychiatry, 2010-11, Vol.44 (11), p.1029-1035

2010

Link zum Volltext

Verfügbarkeit prüfen

Cell proliferation is reduced in the hippocampus in schizophrenia

Australian and New Zealand journal of psychiatry, 2016-05, Vol.50 (5), p.473-480

2016

Link zum Volltext

Verfügbarkeit prüfen

Association between CpG island DNA methylation in the promoter region of RELN and positive and negative types of schizophrenia

Journal of international medical research, 2022-05, Vol.50 (5), p.3000605221100345-3000605221100345

2022

Link zum Volltext

Verfügbarkeit prüfen

An overview on Hebephrenia, a diagnostic cornerstone in the neurodevelopmental model of Schizophrenia

History of psychiatry, 2022-03, Vol.33 (1), p.34-46

2022

Link zum Volltext

Verfügbarkeit prüfen

Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis

Clinical EEG and neuroscience, 2017-01, Vol.48 (1), p.3

2017

Link zum Volltext

Verfügbarkeit prüfen

The Core Deficit of Classical Schizophrenia: Implications for Predicting the Functional Outcome of Psychotic Illness and Developing Effective Treatments

Canadian journal of psychiatry, 2019-10, Vol.64 (10), p.680-685

Liddle, Peter F.

2019

Link zum Volltext

Verfügbarkeit prüfen

A review of anti-inflammatory agents for symptoms of schizophrenia

Journal of psychopharmacology (Oxford), 2013-04, Vol.27 (4), p.337-342

2013

Link zum Volltext

Verfügbarkeit prüfen

Normative values and diagnostic optimisation of three social cognition measures for autism and schizophrenia diagnosis in a healthy adolescent and adult sample

Quarterly journal of experimental psychology (2006), 2024-03, Vol.77 (3), p.511-529

2024

Link zum Volltext

Verfügbarkeit prüfen

Recent genetic findings in schizophrenia and their therapeutic relevance

Journal of Psychopharmacology, 2015-02, Vol.29 (2), p.85-96

2015

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol modulation of hippocampal glutamate in early psychosis

Journal of psychopharmacology (Oxford), 2021-07, Vol.35 (7), p.814-822

2021

Link zum Volltext

Verfügbarkeit prüfen

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment

Journal of psychopharmacology (Oxford), 2016-08, Vol.30 (8), p.717-748

2016

Link zum Volltext

Verfügbarkeit prüfen

Psychotic-Like Experiences in a Community Sample of Adolescents: Implications for the Continuum Model of Psychosis and Prediction of Schizophrenia

Australian and New Zealand journal of psychiatry, 2009-02, Vol.43 (2), p.118-128

2009

Link zum Volltext

Verfügbarkeit prüfen

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Journal of cerebral blood flow and metabolism, 2013-01, Vol.33 (1), p.53-58

2013

Link zum Volltext

Verfügbarkeit prüfen

Reviewing the ketamine model for schizophrenia

Journal of Psychopharmacology, 2014-04, Vol.28 (4), p.287-302

2014

Link zum Volltext

Verfügbarkeit prüfen

Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders

Canadian journal of psychiatry, 2017-09, Vol.62 (9), p.594-603

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 6.609

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete A-Z List

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.487)
Mit Volltextzugriff
(5.197)

Publikationsform

Artikel
(6.502)
Reviews
(105)
Tagungsberichte
(2)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Schizophrenia
(4.727)
Humans
(4.496)
Science & Technology
(4.183)
Life Sciences & Biomedicine
(4.176)
Psychiatry
(3.654)
Male
(2.570)
Adult
(2.332)
Female
(2.317)
Biological And Medical Sciences
(1.627)
Medical Sciences
(1.616)
Psychology. Psychoanalysis. Psychiatry
(1.456)
Middle Aged
(1.404)
Social Sciences
(1.356)
Mental Disorders
(1.273)
Psychopathology. Psychiatry
(1.270)
Psychology
(1.153)
Schizophrenia - Drug Therapy
(1.137)
Schizophrenic Psychology
(1.129)
Psychoses
(853)
Adult And Adolescent Clinical Studies
(850)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SAGE Complete
(6.609)
Journals@Ovid Complete
(3.883)
IngentaConnect
(1.943)
EZB Free E-Journals
(1.898)
EBSCOhost Psychology and Behavioral Sciences Collection
(1.263)
Wiley Online Library
(1.239)
Taylor & Francis Journals Complete
(1.237)
Applied Social Sciences Index & Abstracts (ASSIA)
(1.001)
Publisher or Other Site
(920)
Sociological Abstracts
(476)
JSTOR Complete Journals
(292)
EBSCOhost Business Source Ultimate
(242)
IngentaConnect Journals
(240)
Taylor & Francis Current Content Access
(53)
Nexis
(49)
PAIS Index
(44)
Factiva
(32)
Worldwide Political Science Abstracts
(30)
SpringerNature Journals
(17)
Elsevier ScienceDirect Journals Complete
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)

Menü

Weitere Dienste

Einstellungen

Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries

Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth

Neurocognition: Clinical and Functional Outcomes in Schizophrenia

Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis

The Core of Classical Schizophrenia

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders

Glutamate and dopamine in schizophrenia: An update for the 21st century

Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults

Guidelines for the Pharmacotherapy of Schizophrenia in Adults

A Psychopathological Comparison between Delusional Disorder and Schizophrenia

Australian Schizophrenia Research Bank: A Database of Comprehensive Clinical, Endophenotypic and Genetic Data for Aetiological Studies of Schizophrenia

Cell proliferation is reduced in the hippocampus in schizophrenia

Association between CpG island DNA methylation in the promoter region of RELN and positive and negative types of schizophrenia

An overview on Hebephrenia, a diagnostic cornerstone in the neurodevelopmental model of Schizophrenia

Mismatch Negativity in First-Episode Schizophrenia: A Meta-Analysis

The Core Deficit of Classical Schizophrenia: Implications for Predicting the Functional Outcome of Psychotic Illness and Developing Effective Treatments

A review of anti-inflammatory agents for symptoms of schizophrenia

Normative values and diagnostic optimisation of three social cognition measures for autism and schizophrenia diagnosis in a healthy adolescent and adult sample

Recent genetic findings in schizophrenia and their therapeutic relevance

Cannabidiol modulation of hippocampal glutamate in early psychosis

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment

Psychotic-Like Experiences in a Community Sample of Adolescents: Implications for the Continuum Model of Psychosis and Prediction of Schizophrenia

A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation

Reviewing the ketamine model for schizophrenia

Canadian Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders

Aktive Filter

Suchergebnisse filtern